<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39562810</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>19</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Altered leukocyte pattern and inflammatory markers in unvaccinated long covid patients: a cross-sectional study.</ArticleTitle><Pagination><StartPage>28617</StartPage><MedlinePgn>28617</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-75920-1</ELocationID><Abstract><AbstractText>Long Covid results from the damage caused by SARS-CoV-2, involving the release of cytokines and the continuous activation of immune cells. This cross-sectional study investigates leukocyte and cytokine profiles in Long Covid patients in the Amazon, a region where such studies are limited. Blood samples were analysed for differential leukocyte counts and cytokine levels. We suggest elevated lymphocyte counts in hospitalised patients and those with severe COVID-19. Higher eosinophil counts were observed in patients with up to three months of Long Covid, and increased monocyte counts in those with up to six months. IL-2 levels were higher in patients with fewer symptoms and Long Covid duration of more than three months, whereas IL-10 may remain elevated for up to 12 months. We suggest positive correlations between neutrophils, monocytes, eosinophils, and lymphocytes with different cytokines (IFN-&#x3b3;, IL-6, IL-4, IL-17a, IL-2). Women were associated with lower hospitalisation rates and longer durations of Long Covid; increased lymphocyte counts were linked to hospitalisation due to COVID-19, while higher monocyte counts were associated with Long Covid durations of up to six months. We suggest that Long Covid patients may exhibit alterations in inflammatory markers, indicating a persistently pro-inflammatory microenvironment that tends to diminish after 12 months of Long Covid.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chaves</LastName><ForeName>Elem Cristina Rodrigues</ForeName><Initials>ECR</Initials><Identifier Source="ORCID">0000-0002-6252-6361</Identifier><AffiliationInfo><Affiliation>Department of Center for Biological Health Sciences (CCBS), Graduate Program in Parasitic Biology in Amazonia (PPGBPA), State University of Par&#xe1; (UEPA), Marco, Bel&#xe9;m, Par&#xe1;, 66087-670, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Quaresma</LastName><ForeName>Juarez Ant&#xf4;nio Sim&#xf5;es</ForeName><Initials>JAS</Initials><AffiliationInfo><Affiliation>Department of Center for Biological Health Sciences (CCBS), Graduate Program in Parasitic Biology in Amazonia (PPGBPA), State University of Par&#xe1; (UEPA), Marco, Bel&#xe9;m, Par&#xe1;, 66087-670, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Maria Helena Cruz</ForeName><Initials>MHC</Initials><AffiliationInfo><Affiliation>Metropolitan University Centre of Amazonia (UNIFAMAZ), Bel&#xe9;m, Par&#xe1;, 66053-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Menezes</LastName><ForeName>Daniel Carvalho</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Center for Biological Health Sciences (CCBS), Graduate Program in Parasitic Biology in Amazonia (PPGBPA), State University of Par&#xe1; (UEPA), Marco, Bel&#xe9;m, Par&#xe1;, 66087-670, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lima</LastName><ForeName>Igor Costa</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Department of Center for Biological Health Sciences (CCBS), Graduate Program in Parasitic Biology in Amazonia (PPGBPA), State University of Par&#xe1; (UEPA), Marco, Bel&#xe9;m, Par&#xe1;, 66087-670, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sousa</LastName><ForeName>Jorge Rodrigues</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Morphology and Physiological Sciences (DMCF), State University of Par&#xe1; (UEPA), Bel&#xe9;m, Par&#xe1;, 66087- 670, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gal&#xfa;cio</LastName><ForeName>Vanessa Costa Alves</ForeName><Initials>VCA</Initials><AffiliationInfo><Affiliation>Department of Center for Biological Health Sciences (CCBS), Graduate Program in Parasitic Biology in Amazonia (PPGBPA), State University of Par&#xe1; (UEPA), Marco, Bel&#xe9;m, Par&#xe1;, 66087-670, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Queiroz</LastName><ForeName>Maria Alice Freitas</ForeName><Initials>MAF</Initials><AffiliationInfo><Affiliation>Laboratory of Virology (LABVIR), Institute of Biological Sciences (ICB), Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Par&#xe1;, 66075-110, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brasil-Costa</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Immunology Laboratory, Virology Section, Evandro Chagas Institute (IEC), Health and Environmental Surveillance Secretariat (SVSA), Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barros</LastName><ForeName>Maria Clara</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Laboratory of Human and Medical Genetics (LGHM), Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Par&#xe1;, 66075-110, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro-Dos-Santos</LastName><ForeName>&#xc2;ndrea</ForeName><Initials>&#xc2;</Initials><AffiliationInfo><Affiliation>Laboratory of Human and Medical Genetics (LGHM), Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Par&#xe1;, 66075-110, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Vallinoto</LastName><ForeName>Antonio Carlos Ros&#xe1;rio</ForeName><Initials>ACR</Initials><AffiliationInfo><Affiliation>Laboratory of Virology (LABVIR), Institute of Biological Sciences (ICB), Federal University of Par&#xe1; (UFPA), Bel&#xe9;m, Par&#xe1;, 66075-110, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Falc&#xe3;o</LastName><ForeName>Luiz F&#xe1;bio Magno</ForeName><Initials>LFM</Initials><AffiliationInfo><Affiliation>Department of Center for Biological Health Sciences (CCBS), Graduate Program in Parasitic Biology in Amazonia (PPGBPA), State University of Par&#xe1; (UEPA), Marco, Bel&#xe9;m, Par&#xe1;, 66087-670, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, S&#xe3;o Paulo University (USP), S&#xe3;o Paulo, 01246903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lima</LastName><ForeName>Patr&#xed;cia Danielle Lima</ForeName><Initials>PDL</Initials><Identifier Source="ORCID">0000-0002-1068-2813</Identifier><AffiliationInfo><Affiliation>Department of Center for Biological Health Sciences (CCBS), Graduate Program in Parasitic Biology in Amazonia (PPGBPA), State University of Par&#xe1; (UEPA), Marco, Bel&#xe9;m, Par&#xe1;, 66087-670, Brazil. patricia.lima@uepa.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>005/2020</GrantID><Agency>Amazon Research Foundation (FAPESPA)</Agency><Country/></Grant><Grant><GrantID>006/2020</GrantID><Agency>Amazon Research Foundation (FAPESPA)</Agency><Country/></Grant><Grant><GrantID>#401235/2020-3</GrantID><Agency>The National Council for Scientific and Technological Development</Agency><Country/></Grant><Grant><GrantID>09/2021</GrantID><Agency>Secretariat for Science, Technology and Higher, Professional and Techno-logical Education</Agency><Country/></Grant><Grant><GrantID>Financial code 001, notice no. 13/2020</GrantID><Agency>Coordination for the Improvement of Higher Education Personnel - Brazil</Agency><Country/></Grant><Grant><GrantID>406360/2022-7</GrantID><Agency>National Council for Scientific and Technological Development - Brazil</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007958" MajorTopicYN="N">Leukocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Leukocyte count</Keyword><Keyword MajorTopicYN="N">Long covid</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Competing interests</b> The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>20</Day><Hour>10</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>20</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>20</Day><Hour>0</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39562810</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-75920-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-75920-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carvalho-Schneider, C. et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 27(2), 258&#x2013;263 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai, C. C. et al. Long COVID: an inevitable sequela of SARS-CoV-2 infection. J. Microbiol. Immunol. Infect. 56(1), 1&#x2013;9 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType="pubmed">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Berentschot, J. C. et al. Immunological profiling in long COVID: Overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity. Front Immunol. 14, 1254899 (2023).</Citation></Reference><Reference><Citation>Ribeiro, B. M. S. S. &amp; Carvalho, E. F. D. Post Covid-19 syndrome: Main alterations in the sensory system. Health Environ. Mag. 14(2) (2022).</Citation></Reference><Reference><Citation>Glynne, P. et al. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig Med. 70 (1), 61&#x2013;67 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, J. et al. Distinguishing features of long COVID identified through immune profiling. Nature. 623 (7985), 139&#x2013;148 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId><ArticleId IdType="pmc">10620090</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz, M. A. F. et al. Cytokine profiles associated with Acute COVID-19 and long COVID-19 syndrome. Front. Cell. Infect. Microbiol. 12, 922422 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId><ArticleId IdType="pmc">9279918</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima, I. C. et al. Liver function in patients with Long-Term Coronavirus Disease 2019 of up to 20 months: a cross-sectional study. Int. J. Environ. Res. Public Health. 20(7), 5281 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20075281</ArticleId><ArticleId IdType="pubmed">37047897</ArticleId><ArticleId IdType="pmc">10094195</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xfa;cio, V. C. A. et al. Evaluation of the hematological patterns from up to 985 days of long COVID: A cross-sectional study. Viruses. 15 (4), 879 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040879</ArticleId><ArticleId IdType="pubmed">37112859</ArticleId><ArticleId IdType="pmc">10142608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento, R. A. et al. Effect of long COVID-19 syndrome on health-related quality of life: A cross-sectional study. Front. Psychol. 18 (2024).</Citation></Reference><Reference><Citation>Queiroz, M. A. F. et al. Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-&#x3b1;. Sci. Rep. 14, 4974 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-55696-0</ArticleId><ArticleId IdType="pubmed">38424312</ArticleId><ArticleId IdType="pmc">10904751</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xfa;cio, V. C. A. et al. Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross-sectional study. J. Med. Virol. 96(8) (2024).</Citation></Reference><Reference><Citation>WHO Global Clinical Platform for Clinical Characterization of COVID-19: Statistical Analysis Plan. Dispon&#xed;vel em (2021). https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-Analytic-plan-2021</Citation></Reference><Reference><Citation>Subramanian, A. et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 28(8) (2022).</Citation></Reference><Reference><Citation>Calcaterra, V. et al. Long COVID in children, adults, and vulnerable populations: A comprehensive overview for an integrated approach. Diseases. 12(5), 95 (2024).</Citation></Reference><Reference><Citation>Mohiuddin, C. et al. Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients a prospective multicenter cross-sectional study. Front. Med. 8, 663670 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.663670</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf;, C. et al. From online data collection to identification of disease mechanisms: The IL-1&#xdf;, IL-6 and TNF-&#x3b1; cytokine triad is associated with post-acute sequelae of COVID-19 in a digital research cohort. Lancet, 15 (2021).</Citation></Reference><Reference><Citation>Liu, J. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 55, 102763 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102763</ArticleId><ArticleId IdType="pubmed">32361250</ArticleId><ArticleId IdType="pmc">7165294</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe, S. L. et al. Associations between COVID-19 and hospitalisation with respiratory and non-respiratory conditions: A record linkage study. Med. J. Australia. 218 (1), 33&#x2013;39 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.51778</ArticleId><ArticleId IdType="pubmed">36377203</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaksi, N., Teker, A. G. &amp; Imre, A. Long COVID in hospitalised COVID-19 patients: A retrospective cohort study. Iran. J. Public. Health. 51 (1), 88&#x2013;95 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35223629</ArticleId><ArticleId IdType="pmc">8837882</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong, S. J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. (Lond). 53 (10), 737&#x2013;754 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa, H. A. et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Medicine 2(6), 720&#x2013;735 (2021).</Citation></Reference><Reference><Citation>Lucas, C. A. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 584 (7821), 463&#x2013;469 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId><ArticleId IdType="pmc">7477538</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n, E. et al. Cellular and molecular biomarkers of long COVID: a scoping review. EbioMedicine (2023).</Citation></Reference><Reference><Citation>Krishna, B. A. et al. Spontaneous, persistent, T cell-dependent IFN-&#x3b3; release in patients who progress to Long Covid. Sci. Adv., 10(8) (2024).</Citation></Reference><Reference><Citation>Rodriguez, L. et al. Systems-Level Immunomonitoring from Acute to Recovery phase of severe COVID-19. Cell Rep. Med. 1(5), 100078 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32838342</ArticleId><ArticleId IdType="pmc">7405891</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh, C., Darley, D. R. &amp; Wilson, D. B. Immune dysfunction persists for 8 months after initial mild to moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210&#x2013;216 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker, S. et al. Correction to: mild COVID-19 imprints a long-term inflammatory eicosanoid and chemokine memory in monocyte-derived macrophages. Mucosal Immunol. 15 (4), 798 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-022-00526-7</ArticleId><ArticleId IdType="pubmed">35562559</ArticleId><ArticleId IdType="pmc">9098895</ArticleId></ArticleIdList></Reference><Reference><Citation>Jukema, B. N. et al. Neutrophil and eosinophil responses remain abnormal for several months in primary care patients with COVID-19 disease. Front. Allergy (2022).</Citation></Reference><Reference><Citation>Pereira-Roche, N. et al. Hematological alterations in patients recovered from SARS-CoV-2 infection in Havana, Cuba. MEDICC Rev. 24 (2), 7&#x2013;14 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.37757/mr2022.v24.n2.1</ArticleId><ArticleId IdType="pubmed">35648057</ArticleId></ArticleIdList></Reference><Reference><Citation>Zein, J. G. et al. Eosinophilia is Associated with Improved COVID-19 outcomes in inhaled corticosteroid treated patients. J. Allergy Clin. Immunol. Pract. 10 (3), 742&#x2013;750 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.12.034</ArticleId><ArticleId IdType="pubmed">35033701</ArticleId><ArticleId IdType="pmc">8757367</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauns, E. et al. Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19. JCI Insight (2022).</Citation></Reference><Reference><Citation>Barry, J. C. et al. Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes. Sci. Rep. 6, 21244 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21244</ArticleId><ArticleId IdType="pubmed">26883847</ArticleId><ArticleId IdType="pmc">4756700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelmann, N., Dantzer, R. &amp; Khandaker, G. M. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. 131, 105295 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2021.105295</ArticleId><ArticleId IdType="pubmed">34119855</ArticleId><ArticleId IdType="pmc">8172271</ArticleId></ArticleIdList></Reference><Reference><Citation>Code&#xe7;o, C. T. et al. Epidemiology, biodiversity, and technological trajectories in the Brazilian Amazon: From Malaria to COVID-19. Front. Public. Health. 9, 647754 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.647754</ArticleId><ArticleId IdType="pubmed">34327184</ArticleId><ArticleId IdType="pmc">8314010</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez-Kurtz, G. et al. Pharmacogenomic implications of population admixture: Brazil as a model case. Pharmacogenomics. 15 (2), 209&#x2013;219 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/pgs.13.238</ArticleId><ArticleId IdType="pubmed">24444410</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>